AtriCure (ATRC) Long-Term Investments (2011 - 2023)

AtriCure (ATRC) has 11 years of Long-Term Investments data on file, last reported at $7.6 million in Q2 2023.

• Quarterly Long-Term Investments fell 88.18% year-over-year to $7.6 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $7.6 million (down 88.18% YoY) and the FY2022 annual result came in at $51.5 million, down 50.63% from the prior year.
• Long-Term Investments slipped to $7.6 million in Q2 2023 per ATRC's latest filing, from $25.6 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $105.1 million in Q3 2021 and bottomed at $7.6 million in Q2 2023.
• The 5-year median for Long-Term Investments is $23.0 million (2019), against an average of $40.7 million.
• The widest annual swing landed in 2022, when Long-Term Investments surged 672.59%; it then slumped 88.18% in 2023.
• Tracing ATRC's Long-Term Investments over 5 years: stood at $12.7 million in 2019, then increased by 11.86% to $14.2 million in 2020, then surged by 635.91% to $104.3 million in 2021, then sank by 50.63% to $51.5 million in 2022, then slumped by 85.25% to $7.6 million in 2023.
• Per Business Quant, the three latest ATRC Long-Term Investments figures stand at $7.6 million (Q2 2023), $25.6 million (Q1 2023), and $51.5 million (Q4 2022).

Peer Comparison